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Abstract Retrovirus genomic mRNA exhibits a several hundred
nucleotides-long untranslated region (5P UTR) which encloses
many control elements required for retrovirus replication. In
addition, this 5P UTR contains translation regulatory elements,
such as internal ribosome entry sites (IRESes) that have been
described in oncoretroviruses, as well as in lentiviruses. UV cross-
linking experiments suggested that the pyrimidine tract binding
protein (PTB), a cellular protein known to regulate the activity
of several picornaviral IRESes, binds to human T-cell leukemia
virus (HTLV)-I RNA but not to lentiviral human immunodefi-
ciency virus (HIV)-1, HIV-2 or simian immunodeficiency virus
RNAs. To calculate the affinity of such RNA^protein interac-
tions, we developed a new method based on the BIAcore
technology. The absence of affinity of PTB for lentiviral RNAs
was confirmed, whereas its affinity for HTLV-I RNAs was 1000-
fold lower than for picornaviral RNAs. The BIAcore technology
also revealed a significant affinity of the La autoantigen,
previously described for its involvement in translational control
of viral mRNAs, for HIV-1 and HTLV-I RNAs. Addition of
recombinant PTB to in vitro translation experiments weakly
enhanced translation initiation in the presence of HTLV-I IRES,
suggesting that such an IRES requires additional trans-acting
factors. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Translation initiation of retroviral genomic mRNA has
been shown to occur by an internal ribosome entry mecha-
nism, however very little is known about the proteins involved
in the function of retroviral internal ribosome entry sites
(IRESes).
In contrast, picornaviral IRESes have been shown to spe-
ci¢cally bind cellular proteins (rather than viral factors) able
to enhance their activity. The ¢rst proteins to be identi¢ed
were the pyrimidine tract binding protein (PTB) and the La
autoantigen [1^5]. More recently, the protein unr was shown
to speci¢cally activate the IRES of the human rhinovirus [6].
We report here the interactions of the picornavirus (PV)
and retrovirus 5P untranslated region (5P UTR) (all containing
IRESes) with cellular proteins studied by UV cross-linking
experiments and BIAcore analysis, showing that only human
T-cell leukemia virus (HTLV)-I UTR bound the PTB whereas
HTLV-I and human immunode¢ciency virus (HIV)-1 UTRs
bound La protein. Addition of PTB had only a weak e¡ect on
the translation of a chimeric luciferase mRNA fused to the
HTLV-I 5P UTR.
2. Materials and methods
2.1. Plasmid construction
Plasmid construction strategies are available upon request.
2.2. UV cross-linking experiments
S10 cytoplasmic extracts from di¡erent cell types were prepared as
already described [7]. 1U105 cpm of 32P-labelled RNA was incubated
with 10 Wg of S10 extract and UV-irradiated with an energy of 400 000
WJ/cm2 at 254 nm. The samples were then treated with 2.5 U of
RNase A (Sigma) and 10 U of RNase T1 (Calbiochem) at 37‡C for
30 min, before 12.5% polyacrylamide gel electrophoresis (PAGE)
analysis and autoradiography.
2.3. Recombinant protein puri¢cation
Human PTB and La were overexpressed in Escherichia coli (BL21
strain) as fusion proteins with GST and puri¢ed by glutathione-
Sepharose chromatography (Pharmacia), as recommended by the
manufacturer. Puri¢cation was monitored by SDS^PAGE followed
by Coomassie brilliant blue R-250 staining of the gels. GST-PTB
and GST-La preparations were estimated s 90% pure and their con-
centration was 1 mg/ml.
2.4. BIAcore analysis of RNA^protein interactions
A BIAcore 3000 was used to perform binding studies. Research
grade SA Chips coated with streptavidin were obtained from BIAcore
(Uppsala, Sweden).
A 5P biotinylated single strand DNA probe (hybridizing with the
¢rst 36 ¢re£y luciferase (LucF) nucleotides (nt)) was immobilized on
each £ow cell as capture molecule. The sequence was 3P-TACCTT-
CTGCGGTTTTTGTATTTCTTTCCGGGCCGCG-biotinylated 5P.
0014-5793 / 01 / $20.00 ß 2001 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 1 ) 0 2 1 3 7 - 8
*Corresponding author. Fax: (33)-5-61 32 21 41.
E-mail: pratsac@rangueil.inserm.fr
Abbreviations: EMCV, encephalomyocarditis virus; HIV, human im-
munode¢ciency virus; HTLV, human T-cell leukemia virus; IRES,
internal ribosome entry site; MuLV, murine leukemia virus; nt, nu-
cleotide; ORF, open reading frame; PAGE, polyacrylamide gel elec-
trophoresis; PTB, pyrimidine tract binding protein; RRL, rabbit re-
ticulocyte lysate; SIV, simian immunode¢ciency virus; UTR,
untranslated region
FEBS 24587 2-2-01
FEBS 24587FEBS Letters 490 (2001) 54^58
The immobilization steps were carried out at a £ow rate of 20 Wl/min
in HEPES bu¡er from BIAcore (10 mM HEPES, 150 mM NaCl,
3 mM EDTA and 0.005% P20 surfactant). An average of 1000 relative
units (RU) of DNA was immobilized on each £ow cell.
The mRNA tested was produced from plasmids pKS-JPE (see
above). The mRNAs were then ¢ltered on RNeasy Mini kit from
Qiagen, according to the manufacturer’s instructions. RNA tran-
scripts were then quantitated by absorbance at 260 nm, and their
integrity veri¢ed by ethidium bromide staining on agarose gel. They
were then hybridized over biotinylated DNA at a £ow rate of 5 Wl/min
in modi¢ed HEPES bu¡er (10 mM HEPES, 400 mM NaCl, 3 mM
EDTA and 0.005% P20 surfactant), and the quantities of bound RNA
(i.e. the RU) were monitored. Binding experiments were performed at
a £ow rate of 5 Wl/min. The instrument was equilibrated at 25‡C and
the running bu¡er used was the one obtained from BIAcore. For each
experiment, a £ow cell was coated with an mRNA used as a negative
control of the interaction, pJPE T(3). The response from the control
surface £ow cell was subtracted from the other three £ow cells to
correct the refractive index changes and non-speci¢c binding.
3. Results
3.1. Cell proteins cross-linked to the retroviral RNA leader
sequences
A previous report had shown that PTB binding was corre-
lated to the activity of the Mo-murine leukemia virus (MuLV)
IRES [7]. This prompted us to analyze the cellular proteins
able to bind to the retrovirus leader sequences by UV cross-
linking. 32P-labelled RNA probes corresponding to PV (ence-
phalomyocarditis virus (EMCV)) or retrovirus 5P UTRs
(HIV-1, HIV-2, simian immunode¢ciency virus (SIV),
HTLV-I) were used in UV cross-linking experiments using
acellular extracts from COS-7, HeLa, SK-Hep-1 and Jurkat
cells (Fig. 1A^D). The four kinds of cell extracts gave similar
cross-linking pro¢les for each 5P UTR. A major 60 kDa mi-
grating band was visible using poliovirus and EMCV IRESes
(Fig. 1, PV, EM), probably corresponding to the PTB. This
was con¢rmed by immunoprecipitation using anti-PTB anti-
bodies (data not shown). This 60 kDa protein was clearly
bound to HTLV-I 5P UTR (Fig. 1, HT), but not to HIV-1,
HIV-2 or SIV 5P UTR (Fig. 1, H1, H2, SI). Bands were
detectable, although less clearly, between 40 and 52 kDa using
EMCV, poliovirus, HIV-1 and HTLV-I probes (Fig. 1, PV,
EM, H1, HT), but not with the HIV-2 and SIV leaders (Fig.
1, H2, SI). As expected from the literature, poliovirus,
EMCV, HIV-1 leaders should bind the La protein (47^52
kDa) [3,8,9] : this suggested that one of the cross-linked pro-
teins between 40 and 52 kDa could correspond to La.
3.2. BIAcore analysis of retrovirus RNA leader interactions
with PTB and La
We developed a new approach to characterize and quantify
RNA^protein interactions using the BIAcore technology,
mainly proposed for the study of protein^protein interactions
[10]. Bacterial fusion proteins GST-La and GST-PTB were
puri¢ed (as described in Section 2) to study their interactions
with picornaviral and retroviral RNAs immobilized on strept-
avidin chips bearing a biotinylated DNA with a 3P end com-
plementary to the di¡erent RNAs (Fig. 2).
The results clearly showed that GST-PTB interacted with
EMCV, poliovirus and HTLV-I RNAs, but not with HIV-1,
HIV-2 and SIV RNAs (Fig. 3). GST-La showed a⁄nity with
EMCV, poliovirus, HIV-1 and HTLV-I, but not with HIV-2
and SIV RNAs. These data not only con¢rmed the UV cross-
linking experiments, but enabled us to calculate the apparent
a⁄nity constants (KD) for each interaction. We measured a
KD of 4 and 5 pM for GST-PTB interactions with EMCV and
PV RNAs, respectively, and a KD of 5.3 nM for its interaction
with HTLV-I RNA. GST-La bound to HIV-1 RNA with a
Fig. 1. Analysis of RNA^protein interactions by UV cross-linking.
(A) COS-7, (B) HeLa, (C) SK-Hep-1 and (D) Jurkat cells S10 ex-
tract were incubated with RNA probes (105 cpm) corresponding to
the di¡erent PV (EMCV nt 261^837, poliovirus) or retrovirus lead-
ers (HIV-1, HIV-2, SIV and HTLV-I). UV irradiation was per-
formed as described in Section 2. Samples were treated with RNases
A and T1 before analysis by SDS^PAGE. The name of the probe is
indicated under each lane: PV (poliovirus), EM (EMCV), H1 (HIV-
1), H2 (HIV-2), SI (SIV), HT (HTLV-I). Migration of the size stan-
dards (kDa) is shown. The arrow indicates PTB migration.
Fig. 2. Scheme of RNA^protein interaction on BIAcore 3000. The
di¡erent viral RNA 5P UTRs (transcribed using the MEGAscriptR
T7 kit from Ambion) were fused to the ¢rst 36 nt of LucF ORF.
These RNAs were bound to a streptavidin sensorchip by the inter-
mediary of a biotinylated DNA oligonucleotide complementary to
the 36 nt of LucF ORF. Binding experiments were performed on
BIAcore 3000 using puri¢ed GST-PTB, GST-La or GST alone as a
control.
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Fig. 3. BIAcore analysis of viral RNA leader interactions with GST-PTB and GST-La. Analysis of mRNA interactions with proteins by sur-
face plasmon resonance. The sensograms show the relative responses for the interaction tested. Amounts of mRNA captured onto biotinylated
single strand DNA probe are indicated (as described in Section 2). GST proteins were injected over the £ow cell at the indicated concentra-
tions. Apparent values for KD were calculated using Biaevaluation 3.1 from BIAcore.
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KD of 20 nM, whereas it was only 0.3 and 0.6 nM with HIV-1
and HTLV-I RNAs.
These data indicated that GST-PTB binds to HTLV-I RNA
and GST-La to HIV-1 and HTLV-I RNAs, but with much
lower a⁄nity than to the picornaviral RNAs, which was not
visible on the cross-linking autoradiogram. Furthermore they
provided evidence that PTB does not bind to HIV-1, HIV-2
and SIV RNAs and that La does not bind to HIV-2 and SIV
RNAs.
3.3. The e¡ect of PTB addition on translation e⁄ciency in vitro
is correlated to its a⁄nity for RNA
The results obtained from the cross-linking and BIAcore
experiments suggested that PTB could be a trans-acting factor
able to promote or enhance the retrovirus IRES activities
depending on their binding to these IRESes. To test this hy-
pothesis, in vitro translation experiments were performed with
monocistronic mRNAs bearing EMCV, HTLV-I or HIV-1 5P
UTR fused to the LucF open reading frame (ORF). GST-
PTB protein was added to the translation reactions and lucif-
erase synthesis compared in the absence or presence of the
protein. The results are reported in Fig. 4: for each mRNA,
the e¡ect of the protein is expressed by an activation factor
corresponding to the ratio of Luc activity in the presence
versus absence of GST-PTB. A negative control without any
IRES was also used (Fig. 4, CT). PTB was able to activate
EMCV IRES e⁄ciency by an 11-fold factor (Fig. 4, EMCV).
In contrast, PTB was only able to activate translation in the
presence of the HTLV-I 5P UTR by a 2.3-fold factor in the
same conditions (Fig. 4, HTLV-I). The e¡ect of PTB addition
was still lower in the presence of HIV-1 5P UTR (U1.6, Fig. 4,
HIV-1).
These experiments showed that PTB had di¡erent e¡ects on
translation of the LucF mRNA, depending on the presence of
EMCV, HTLV-I or HIV-1 5P UTRs. Such di¡erences re-
£ected the di¡erent a⁄nities of PTB for the three RNAs,
shown in Fig. 3.
4. Discussion
We show here, by the BIAcore technology, that the 5P
UTRs of picornaviral and retroviral mRNAs have di¡erent
a⁄nities for PTB and La proteins. The most striking di¡er-
ences are observed with PTB, and are correlated with the
ability of the protein to enhance translation in the presence
of these di¡erent 5P UTRs in vitro.
On a technological point of view, these results show that
surface plasmon resonance (BIAcore) provides a powerful ap-
proach for measuring RNA^protein a⁄nity. Whereas the UV
cross-linking experiments provided a qualitative information
as regards the ability of PTB to bind to the di¡erent RNAs,
the BIAcore analysis revealed a 1000-fold di¡erence between
the a⁄nity of PTB for PV and HTLV-I RNAs, whereas it
con¢rmed the absence of binding of PTB to the HIV-1 5P
UTR RNA.
The better a⁄nity of PTB for a PV 5P UTR than for a
retrovirus 5P UTR RNA has already been observed for Mo-
MuLV, in competition experiments involving UV cross-link-
ing assays [7]. The a⁄nity of the La protein for HIV-1 UTR is
also lower than its a⁄nity for poliovirus (KD of 0.3 and 20
nM, respectively). This is consistent with a previous report
describing a 6-fold higher a⁄nity of poliovirus RNA for La
than of HIV-1 TAR RNA [8]. The bigger KD di¡erence ob-
served in our experiments can be explained by the fact that we
used the complete HIV-1 5P UTR.
IRESes have been identi¢ed in the genomic mRNA 5P UTR
of both lenti- and oncoretroviruses [7,11^13] whereas PTB
seems to bind to the mRNA 5P UTR of oncoretroviruses
only [7] (and this report). This suggests that PTB might be
involved in the function of oncoretrovirus, but not lentivirus
IRESes. However the supplementation of rabbit reticulocyte
lysate (RRL) with puri¢ed GST-PTB (Fig. 3), fully active on
EMCV IRES activation (11-fold), results in a weak enhance-
ment of HTLV-I IRES (2.3-fold), that is barely superior to
the enhancement observed for HIV-1 IRES (1.6) which has no
a⁄nity for the protein (see above). We may hypothesize that
PTB is not a determinant trans-acting factor for the oncore-
trovirus IRES function, or that it is not su⁄cient alone to
enhance IRES activity, another protein being required. Sup-
porting the second hypothesis, we observed in co-transfection
experiments that PTB activated the expression of a monocis-
tronic HTLV-I-CAT (chloramphenicol acetyltransferase)
mRNA in COS-7 cells (data not shown). Furthermore a re-
cent report shows that foot and mouth disease virus IRES
requires both PTB and another factor, ITAF(45), acting as
RNA chaperones [14]. Thus, the weak enhancing e¡ect of
PTB on translation e⁄ciency in the presence of the onco-
retrovirus IRES suggests the requirement of a co-factor for
optimal IRES activity.
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